AI
Predictability failures in AlphaFold 3 drug discovery pipelines
AlphaFold 3 faces technical vulnerabilities in protein-nucleic acid complexes following a Novartis trial failure. Structural errors like overlapping atoms and spurious alpha helices persist despite a 50% improvement in protein interaction accuracy.